Cocrystal Pharma, Inc. (COCP)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-139.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $2.01M | $6.56M | — | — | — |
| Operating Income | -$9.02M | -$17.88M | -$18.56M | -$38.83M | -$14.22M | -$9.59M | -$48.41M | -$62.92M | -$8.26M | -$105.82M |
| Net Income | -$8.83M | -$17.50M | -$17.98M | -$38.84M | -$14.19M | -$9.65M | -$48.17M | -$49.05M | -$613.0K | -$74.87M |
| EPS (Diluted) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | $-0.16 | — | — | — | $-0.03 | $-3.18 |
| Total Assets | $9.71M | $13.46M | $31.26M | $40.84M | $79.39M | $54.24M | $28.53M | $68.56M | $121.43M | $124.88M |
| Total Liabilities | $3.38M | $3.93M | $4.88M | $1.27M | $1.84M | $1.74M | $2.82M | $1.67M | $16.03M | $22.56M |
| Shareholders' Equity | $6.33M | $9.52M | $26.38M | $39.60M | $77.55M | $52.51M | $25.71M | $66.89M | $105.40M | $102.32M |
| Cash & Equivalents | $7.03M | $9.86M | $26.35M | $37.14M | $58.70M | $33.01M | $7.42M | — | $748.0K | $3.60M |
| Operating Cash Flow | -$8.19M | -$16.48M | -$14.67M | -$21.43M | -$12.72M | -$9.83M | -$1.56M | -$8.29M | -$6.90M | -$14.65M |
| Capital Expenditures | $12.0K | $8.0K | $118.0K | $74.0K | $52.0K | $240.0K | $145.0K | $28.0K | $40.0K | $51.0K |
| Shares Outstanding | 13.78M | 10.17M | 10.17M | 8.14M | 8.14M | 70.44M | 35.15M | 29.94M | 24.27M | 23.80M |